Stephen P Lockhart

5PUBLICATIONS
27CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 22, 2026
Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.

|May 25, 2026
Randomized Phase 3 Comparison of a 2-Dose and 3-Dose Regimen of a Detoxified Toxin A/B Clostridioides difficile Vaccine in Adults 50 Years and Older.

|Dec 08, 2025
T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in Children.

Isabel Vogler, Stephanie Renken, Rolf Hilker

|Dec 15, 2021
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.

Miwa Haranaka, James Baber, Yoichiro Ogama

|May 25, 2016
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever.

Christoph J Blohmke, Thomas C Darton, Claire Jones

Pageof 1

Frequent Collaborators

3 joint publications

Nicholas Kitchin

2 joint publications

Kena A Swanson

2 joint publications

William C Gruber

1 joint publications

Jasmin Quandt